Is urax a good buy today?

URAX is not a good buy today. Here's why:

1. Lack of Performance Data: The percentage change and price of URAX are not available, making it difficult to assess its current position or potential for growth.
2. Recent Launch: URAX is a newly launched ETF, which means it lacks a track record of performance for investors to evaluate. Typically, new funds are more volatile and come with higher risk as they are still building their portfolios and establishing their strategies.
3. Market Volatility: The uranium market, like any commodity market, is subject to price fluctuations based on global supply and demand dynamics. At the moment, there are no specific indicators suggesting a favorable market condition for uranium.
4. High Leverage: URAX is a 2X leveraged ETF, which amplifies both positive and negative returns. This means that while it offers the potential for higher profits, it also carries a higher risk of loss, especially in a volatile market.

Given these points, it's advisable to conduct thorough research on URAX's underlying assets, the uranium market, and Defiance's track record before making an investment decision. It's also crucial to consider your own risk tolerance and investment goals.